2023-08-07T14:37:11-05:00 2022-12-31 582676261 Rogers & Company PLLC 8300 Boone Boulevard Suite 600 Vienna VA 22182 990 2022-01-01 263727917 Reagan-Udall Foundation for the Food and Drug Administration Inc REAG 2028492075 1333 New Hampshire Ave NW 420 Washington DC 20036 Susan C Winckler RPh Esq Chief Executive Officer 2028492075 2023-08-07 1 Susan Winckler RPh Esq 999009999 1 Jie Chen CPA P01049760 7038930300 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z X Susan C Winckler RPh E 1333 New Hampshire Ave NW 420 Washington DC 20036 8855372 0 X www.reaganudall.org X 2009 MD Advance the mission of the Food and Drug Administration to modernize product development, accelerate innovation, and enhance product safety. 17 17 18 0 0 0 2762920 5204924 2725836 3614197 1358 30611 -54203 -97503 5435911 8752229 0 0 0 0 2020640 2344902 0 0 181612 3283043 6288520 5303683 8633422 132228 118807 4910430 8144687 1274367 4398051 3636063 3746636 X Advance the mission of the Food and Drug Administration to modernize product development, accelerate innovation, and enhance product safety. 1 0 7286771 3422449 Encourage innovative research & analysis - Provide data assets and analysis tools to examine the risks and benefits of regulated products. Examples include the COVID-19 Evidence Accelerator, the Innovation in Medical Evidence and Development Surveillance (IMEDS) Program, and the Algorithm Validation Studies Program. 191187 47284 Improve public understanding of the risks and benefits of FDA-regulated products - Identify priority areas for consumer, patient, and provider education in areas of emerging science. Examples include the Skin Lightening Consumer Safety Project, Expanded Access Navigator, COVID-19 Hub, Antimicrobial Use Data in Food Animals, and the Nutrition Communication Network. 743447 144465 Facilitate multi-stakeholder collaboration - Enable expert analysis and candid discussion on issues relevant to the FDA mission. Examples include Patient Listening Sessions, Substance Use Disorders, and multiple expert convenings. 12982 Education - The newly created Fellowship inRegulatory Science, Innovation, and Health Equityprovides a hands-on learning opportunity for professional school graduates. 12982 8234387 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 41 0 1 18 0 0 0 0 0 0 1 1 0 0 0 0 0 0 X 17 17 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 X Dave Woodbury 2028492067 1333 New Hampshire Ave NW 420 Washington DC 20036 Ellen V Sigal PhD Chair 4.00 X X 0 0 0 Richard L Schilsky MD FACP FSCT, FASCO, Vice Chair 4.00 X X 0 0 0 Allan Coukell BScPharm Secretary/Treasurer 4.00 X X 0 0 0 Helen Darling MA Director 4.00 X 0 0 0 Jonathan Leff MBA Director 4.00 X 0 0 0 Adrian F Hernandez MD MHS Director 4.00 X 0 0 0 Georges C Benjamin MD MACP FNAPA FACEP(E), Hon FRSPH & FFPH, Director 4.00 X 0 0 0 Lynne Zydowsky PhD Director 4.00 X 0 0 0 Molly Fogarty Director 4.00 X 0 0 0 Andrew C von Eschenbach MD Director 4.00 X 0 0 0 Christie Boutte PharmD RPh Director 4.00 X 0 0 0 Phil Febbo MD Director 4.00 X 0 0 0 James EK Hildreth PhD MD Director 4.00 X 0 0 0 David C Fajgenbaum MD MBA MSc, FCPP, Director 4.00 X 0 0 0 William N Hait MD PhD Director 4.00 X 0 0 0 Debra L Ness MS Director 4.00 X 0 0 0 Edward John Allera JD Director 4.00 X 0 0 0 Susan C Winckler RPh JD Chief Executive Officer 40.00 X 406668 0 32836 Amar Bhat PhD Chief Operating Officer 40.00 X 210482 0 28416 Lea Ann Browning-McNee MA Director of Communications & Stakeholder Engagemen 40.00 X 176596 0 26848 Carla Rodriguez-Watson PhD Director of Research 40.00 X 207310 0 22871 David Woodbury MBA Director of Operations 40.00 X 170613 0 27422 1171669 0 138393 8 0 1 0 0 410000 4754372 40552 5204924 IMEDS Contract 541900 3614197 3614197 3614197 30611 30611 4550 410000 103143 -98593 -98593 Other 900099 1090 1090 1090 8752229 3614197 0 -66892 X 678405 607810 26642 43953 1340019 1200578 52624 86817 76450 68495 3002 4953 116005 103934 4556 7515 134023 120077 5263 8683 111885 111597 118 170 107180 107180 5482900 5467590 6242 9068 34543 34454 37 52 23709 22211 591 907 144259 140598 1446 2215 188524 172803 6448 9273 1547 1482 5 60 82026 78572 268 3186 45316 42452 1129 1735 9203 8622 229 352 Professional Developmen 32887 29465 1291 2131 Dues and Subscriptions 13634 12773 339 522 IRB expense 10810 10783 11 16 Business registration & 97 91 2 4 8633422 8234387 217423 181612 535948 490499 3027633 2775826 498455 750430 726936 1721442 55376 33861 403621 287830 52050 115791 769732 7500 14032 1479606 4910430 8144687 1143047 2856234 120839 10481 1541817 1274367 4398051 X 3578725 3689939 57338 56697 3636063 3746636 4910430 8144687 118807 -8233 0 X X 0 1 X 1 1 1 X 1847894 1800144 2391995 2762920 5204924 14007877 1847894 1800144 2391995 2762920 5204924 14007877 384485 13623392 9575 35048 22326 1358 30611 98918 1144 1090 2234 14109029 10319404 0.96560 0.88800 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 26254 1875 24379 177491 90078 87413 199876 195877 3999 115791 Deposits 26308 Right-of-use assets - operating lease 1453298 1479606 Lease liability - operating lease 1541817 1541817 X 8847139 -8233 103143 94910 8752229 0 8752229 8736566 103143 103143 8633423 0 8633423 Part X, Line 2: Management has evaluated the Foundation's tax positions and concluded that the Foundation's financial statements do not include any uncertain tax positions. Part XI, Line 2d - Other Adjustments: Direct benefits to donors 103,143. Part XII, Line 2d - Other Adjustments: Direct benefits to donors 103,143. 2022 Awards Gala 414550 410000 4550 103143 414550 410000 4550 103143 103143 -98593 X 0 0 0 0 0 0 0 0 0 Susan C Winckler RPh JD Chief Executive Officer 406668 0 0 0 0 0 18300 0 14536 0 439504 0 0 0 Amar Bhat PhD Chief Operating Officer 207482 0 3000 0 0 0 12629 0 15787 0 238898 0 0 0 Carla Rodriguez-Watson PhD Director of Research 204310 0 3000 0 0 0 12439 0 10432 0 230181 0 0 0 Lea Ann Browning-McNee MA Director of Communications & Stakeho 173596 0 3000 0 0 0 10596 0 16252 0 203444 0 0 0 David Woodbury MBA Director of Operations 166863 0 3750 0 0 0 10012 0 17410 0 198035 0 0 0 Form 990, Part III, line 2 Education - The newly created Fellowship inRegulatory Science, Innovation, and Health Equityprovides a hands-on learning opportunity for professional school graduates. Form 990, Part VI, Section B, line 11b After the Form 990 is prepared by the independent accountants it is reviewed by the Chief Executive Officer and the Treasurer before being filed with the IRS. Form 990, Part VI, Section B, line 12c No director, officer, employee, fellow or trainee of the Foundation (hereinafter "Interested Persons") shall take any action on or participate in the consideration or determination of any Foundation matter in which he or she, his or her spouse, minor child, general partner, non-federal organization in which he or she is serving as an officer, director, trustee, general partner or employee, or any person or nonfederal organization with whom he or she is negotiating or has any arrangement concerning potential employment, has a financial interest. In addition to actual conflicts of interest, Interested Persons are also obliged to avoid actions that could be perceived or interpreted to be in conflict with the Foundation's best interests. Interested Persons shall disclose their financial interest in entities doing business with the Foundation and refrain from participating in decisions affecting transactions between the Foundation and those other entities without approval by the Board of Directors. Form 990, Part VI, Section B, line 15a The CEO's performance and compensation is annually reviewed and approved by the Executive Committee with input from the Board. This entire process is documented. Salaries of all staff are reviewed annually by the CEO using compensation survey data for comparable size and type organizations. Form 990, Part VI, Section C, line 19 The Foundation makes its governing documents, conflict of interest policy, and financial statements available to the public upon request. Form 990, Part IX, line 11g Temporary staff expense: Program service expenses 10,479. Management and general expenses 459. Fundraising expenses 758. Total expenses 11,696. Data partners: Program service expenses 2,928,783. Management and general expenses 3,103. Fundraising expenses 4,460. Total expenses 2,936,346. Staff recruiting expense: Program service expenses 27,918. Management and general expenses 30. Fundraising expenses 42. Total expenses 27,990. Payroll service fees: Program service expenses 3,939. Management and general expenses 5. Fundraising expenses 6. Total expenses 3,950. Other professional fees: Program service expenses 36,508. Management and general expenses 38. Fundraising expenses 56. Total expenses 36,602. Program consultants: Program service expenses 2,459,963. Management and general expenses 2,607. Fundraising expenses 3,746. Total expenses 2,466,316. Form 990, Part XII, Line 2c: The Foundation's Finance Committee is responsible for oversight of the audit, including selection of the independent accountant. The process has not changed from prior years.